Adagene Inc. Share Price
NASDAQ: ADAGAdagene Inc. Stock Performance
Adagene Inc. Share Price Today
As of 30 October 2026, Adagene Inc.'s share price is $2.69. The stock opened at $2.72, compared to its previous close of $2.69. During today's trading session, Adagene Inc.'s share price traded between $2.64 and $2.72, with an average price of $2.68. Over the past 52 weeks, the stock has recorded a high of $4.85 and a low of $1.33. In terms of performance, Adagene Inc.'s share price has declined by 26.70% over the last six months and is up 51.12% on a year-on-year basis.
Adagene Inc. Share Price Chart
Adagene Inc. Annual Profit & Loss
All figures in USD
About Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
Adagene Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.09 | $2.65 | -17.32% |
Sep 2026 | $3.58 | $3.21 | -18.14% |
Aug 2026 | $3.69 | $3.92 | +4.54% |
Jul 2026 | $4.02 | $3.75 | -11.47% |
Jun 2026 | $3.80 | $4.23 | +6.42% |
May 2026 | $3.74 | $3.98 | +8.31% |
Apr 2026 | $4.13 | $3.67 | -9.16% |
Mar 2026 | $2.95 | $4.04 | +32.03% |
Feb 2026 | $2.70 | $3.06 | +10.47% |
Jan 2026 | $1.78 | $2.77 | +46.56% |
Dec 2025 | $2.07 | $1.89 | -8.70% |
Nov 2025 | $1.77 | $2.07 | +16.29% |